Effect of GlucoSEB™ Supplement on the Blood Glucose Level in Diabetic Patients: A Case Study

Abstract

Diabetes is becoming a globally prevalent disease that puts a burden on healthcare systems and poses challenges to risk management.
Diabetes leads to microvascular and macrovascular complications. Therefore, maintaining normoglycemia is essential to improving
the quality of life and preventing morbidity and mortality in people with diabetes (PwD). A current study was performed
to check the effect of GlucoSEB™ supplement on the blood glucose level of Type 2 diabetes mellitus (T2DM) patients. Subjects
in this study were blinded to the treatment; they received a placebo for the initial seven days, followed by GlucoSEB™ for the next
seven days. Blood glucose was monitored with a continuous glucose monitoring (CGM) device. Administration of GlucoSEB™
caused a decrease in blood glucose level, glucose area under the curve (AUC), and an improvement in time in range (TIR). Also,
GlucoSEB™ was well tolerated by all the patients, indicating the safety of the supplement. Thus, GlucoSEB™ supplementation
positively influenced blood glucose parameters and helped curb blood glucose excursions.